Boosting your own immune cells to improve the uterine lining
Part of Women’s health & pregnancy clinical trials.
This study gives a small amount of your own immune cells into the uterus to change the immune environment in the uterine lining. It aims to improve how the uterine lining supports implantation, especially for people trying to conceive with embryo transfer of normal (euploid) embryos.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently doing fertility treatment that includes embryo transfer
- You have primary infertility (no prior successful pregnancy) and regular periods
- You are told you have an unusual immune-cell pattern in the uterine lining
- You have an embryo transfer planned using euploid embryos (normal chromosome results)
- You do not have major uterine problems (uterine pathologies)
- You do not have uterine infection or active uterine inflammation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether platelet-rich plasma (PRP)—a concentration of healing cells from your own blood—injected into the uterus can improve the uterine lining and help embryos implant successfully during fertility treatment. Researchers will check how the treatment changes immune cells in the uterus.
This trial tests a new treatment using stem cell particles (exosomes) to help rebuild the lining of the womb in women whose lining is too thin after surgery for scar tissue. It may improve chances of success with IVF.
This trial studies whether giving your own immune cells (PBMC) to the uterus, modified with interferon (IFN‑t), can improve how endometrial (uterine lining) cells behave during infertility treatment. It may help some people with primary infertility who are undergoing assisted reproduction.
This trial studies whether placing your own immune cells (PBMCs) that have been adjusted with a medicine called IFN-<i>t</i> before embryo transfer can improve IVF success. It may help support the uterine environment around the time of implantation.
This study looks at whether testing the immune cells in the uterus and then personalizing treatment improves the chance of success for patients who have a single embryo transfer. Eligible patients had the immune test and then a single blastocyst transfer within nine months.
This trial studies how the immune system in the uterus may impact whether a genetically normal frozen embryo implants successfully. It aims to help improve success rates for women undergoing IVF.
Hear when a new Female Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.